Increased Insertion of Glutamate Receptor 2-Lacking α-Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid (AMPA) Receptors at Hippocampal Synapses upon Repeated Morphine Administration
Evidence suggests that the long-term adaptations in the hippocampus after repeated drug treatment may parallel its role during memory formation. The neuroplasticity that subserves learning and memory is also believed to underlie addictive processes. We have reported previously that repeated morphine...
Gespeichert in:
Veröffentlicht in: | Molecular pharmacology 2010-05, Vol.77 (5), p.874-883 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 883 |
---|---|
container_issue | 5 |
container_start_page | 874 |
container_title | Molecular pharmacology |
container_volume | 77 |
creator | Billa, Sophie K. Liu, Jie Bjorklund, Nicole L. Sinha, Namita Fu, Yu Shinnick-Gallagher, Patricia Morón, Jose A. |
description | Evidence suggests that the long-term adaptations in the hippocampus after repeated drug treatment may parallel its role during memory formation. The neuroplasticity that subserves learning and memory is also believed to underlie addictive processes. We have reported previously that repeated morphine administration alters local distribution of endocytic proteins at hippocampal synapses, which could in turn affect expression of glutamate receptors. Glutamatergic systems, including α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs), are believed to be involved in opiate-induced neuronal and behavioral plasticity, although the mechanisms underlying these effects are only beginning to be understood. The present study further examines the effects of repeated morphine administration on the expression and composition of AMPARs and the functional ramifications. Twelve hours after the last morphine injection, we observed an increased expression of AMPARs lacking glutamate receptor (GluR) 2 in hippocampal synaptic fractions. Immunoblotting studies show that 12 h after morphine treatment, GluR1 subunits are increased at the postsynaptic density (PSD) and at extrasynaptic sites, whereas GluR3 subunits are only increased at the PSD, and they show how this alters receptor subunit composition. In addition, we provide electrophysiological evidence that AMPARs are switched to Ca2+-permeable (GluR2-lacking) at the synapse 12 h after repeated morphine treatment, affecting the magnitude of long-term depression at hippocampal neurons. We propose that morphine-induced changes in glutamatergic synaptic transmission in the hippocampus may play an important role in the neuroadaptations induced by repeated morphine administration. |
doi_str_mv | 10.1124/mol.109.060301 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2872965</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0026895X24026804</els_id><sourcerecordid>20159947</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-1ac14bb227e19a80aa79c8708ba31f2cfaf2fb3d655afc4f65e45c8b91defbfc3</originalsourceid><addsrcrecordid>eNp1kc1u1DAUhS0EokNhyxJ5CQsPthPnZ4MUVdCONBVVAYmd5TjXHUNiW3amangrlrwEz4SrgREsWF1L99zvHOsg9JzRNWO8fD35cc1ou6YVLSh7gFZMcEYoY-whWlHKK9K04vMJepLSF0pZKRr6GJ1wykTblvUK_dg4HUElGPDGJYiz9Q57g8_H_awmNQO-Bg1h9hFzslX6q3U3-Od30k3WeVKQ3TJEf7cQQSaYd8tISmKTv1Pf_Aj4KvqQeVbjTtsBv-wur7pXR2DCasYXNgSv1RTUiD8sToUECe9DDnENAbL_gC99DDvrAHdDNrVpjuo-5VP0yKgxwbPf8xR9evf249kF2b4_35x1W6LLopkJU5qVfc95DaxVDVWqbnVT06ZXBTNcG2W46YuhEkIZXZpKQCl007dsANMbXZyiNwdu2PcTDBpcDjDKEO2k4iK9svLfjbM7eeNvJW9q3lYiA9YHgI4-pQjmeMuovC9R5hLzu5WHEvPBi78dj_I_rWVBcxBA_vethSiTtuA0DDaCnuXg7f_YvwD5arHr</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Increased Insertion of Glutamate Receptor 2-Lacking α-Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid (AMPA) Receptors at Hippocampal Synapses upon Repeated Morphine Administration</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Billa, Sophie K. ; Liu, Jie ; Bjorklund, Nicole L. ; Sinha, Namita ; Fu, Yu ; Shinnick-Gallagher, Patricia ; Morón, Jose A.</creator><creatorcontrib>Billa, Sophie K. ; Liu, Jie ; Bjorklund, Nicole L. ; Sinha, Namita ; Fu, Yu ; Shinnick-Gallagher, Patricia ; Morón, Jose A.</creatorcontrib><description>Evidence suggests that the long-term adaptations in the hippocampus after repeated drug treatment may parallel its role during memory formation. The neuroplasticity that subserves learning and memory is also believed to underlie addictive processes. We have reported previously that repeated morphine administration alters local distribution of endocytic proteins at hippocampal synapses, which could in turn affect expression of glutamate receptors. Glutamatergic systems, including α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs), are believed to be involved in opiate-induced neuronal and behavioral plasticity, although the mechanisms underlying these effects are only beginning to be understood. The present study further examines the effects of repeated morphine administration on the expression and composition of AMPARs and the functional ramifications. Twelve hours after the last morphine injection, we observed an increased expression of AMPARs lacking glutamate receptor (GluR) 2 in hippocampal synaptic fractions. Immunoblotting studies show that 12 h after morphine treatment, GluR1 subunits are increased at the postsynaptic density (PSD) and at extrasynaptic sites, whereas GluR3 subunits are only increased at the PSD, and they show how this alters receptor subunit composition. In addition, we provide electrophysiological evidence that AMPARs are switched to Ca2+-permeable (GluR2-lacking) at the synapse 12 h after repeated morphine treatment, affecting the magnitude of long-term depression at hippocampal neurons. We propose that morphine-induced changes in glutamatergic synaptic transmission in the hippocampus may play an important role in the neuroadaptations induced by repeated morphine administration.</description><identifier>ISSN: 0026-895X</identifier><identifier>EISSN: 1521-0111</identifier><identifier>DOI: 10.1124/mol.109.060301</identifier><identifier>PMID: 20159947</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>(2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino-2-hydroxypropyl](phenylmethyl)phosphinic acid hydrochloride ; 2-amino-5-phosphonovalerate ; ACSF ; AMPA ; AMPAR ; analysis of variance ; Animals ; ANOVA ; artificial cerebral spinal fluid ; CGP55845 ; d-APV ; EPSC ; excitatory postsynaptic currents ; Excitatory Postsynaptic Potentials - drug effects ; Excitatory Postsynaptic Potentials - physiology ; extracellular field excitatory postsynaptic potential ; fEPSP ; fiber volley ; GABA Antagonists - pharmacology ; HFS ; high-frequency stimulation ; immunoprecipitation ; Joro spider toxin ; JST ; LFS ; long-term depression ; long-term potentiation ; Long-Term Potentiation - drug effects ; Long-Term Potentiation - physiology ; low-frequency stimulation ; LTD ; LTP ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Morphine - pharmacology ; N-(2,6-dimethylphenylcarbamoylmethyl)triethylammonium ; N-methyl-d-aspartate ; N-methyl-d-aspartate receptor ; NMDA ; NMDAR ; paired-pulse facilitation ; philanthotoxin ; Phosphinic Acids - pharmacology ; Phosphorylation ; Phtx ; picrotoxin ; Picrotoxin - pharmacology ; postsynaptic density ; PPF ; Propanolamines - pharmacology ; Protein Subunits - drug effects ; Protein Subunits - genetics ; PSD ; PTX ; QX314 ; Receptors, AMPA - biosynthesis ; Receptors, AMPA - deficiency ; Receptors, AMPA - drug effects ; Receptors, AMPA - genetics ; Receptors, AMPA - physiology ; rectification index ; Synapses - drug effects ; Synapses - physiology ; Synaptic Transmission - drug effects ; Synaptic Transmission - physiology ; ventral tegmental area ; VTA ; α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid ; α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor</subject><ispartof>Molecular pharmacology, 2010-05, Vol.77 (5), p.874-883</ispartof><rights>2010 American Society for Pharmacology and Experimental Therapeutics</rights><rights>Copyright © 2010 The American Society for Pharmacology and Experimental Therapeutics</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-1ac14bb227e19a80aa79c8708ba31f2cfaf2fb3d655afc4f65e45c8b91defbfc3</citedby><cites>FETCH-LOGICAL-c438t-1ac14bb227e19a80aa79c8708ba31f2cfaf2fb3d655afc4f65e45c8b91defbfc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20159947$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Billa, Sophie K.</creatorcontrib><creatorcontrib>Liu, Jie</creatorcontrib><creatorcontrib>Bjorklund, Nicole L.</creatorcontrib><creatorcontrib>Sinha, Namita</creatorcontrib><creatorcontrib>Fu, Yu</creatorcontrib><creatorcontrib>Shinnick-Gallagher, Patricia</creatorcontrib><creatorcontrib>Morón, Jose A.</creatorcontrib><title>Increased Insertion of Glutamate Receptor 2-Lacking α-Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid (AMPA) Receptors at Hippocampal Synapses upon Repeated Morphine Administration</title><title>Molecular pharmacology</title><addtitle>Mol Pharmacol</addtitle><description>Evidence suggests that the long-term adaptations in the hippocampus after repeated drug treatment may parallel its role during memory formation. The neuroplasticity that subserves learning and memory is also believed to underlie addictive processes. We have reported previously that repeated morphine administration alters local distribution of endocytic proteins at hippocampal synapses, which could in turn affect expression of glutamate receptors. Glutamatergic systems, including α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs), are believed to be involved in opiate-induced neuronal and behavioral plasticity, although the mechanisms underlying these effects are only beginning to be understood. The present study further examines the effects of repeated morphine administration on the expression and composition of AMPARs and the functional ramifications. Twelve hours after the last morphine injection, we observed an increased expression of AMPARs lacking glutamate receptor (GluR) 2 in hippocampal synaptic fractions. Immunoblotting studies show that 12 h after morphine treatment, GluR1 subunits are increased at the postsynaptic density (PSD) and at extrasynaptic sites, whereas GluR3 subunits are only increased at the PSD, and they show how this alters receptor subunit composition. In addition, we provide electrophysiological evidence that AMPARs are switched to Ca2+-permeable (GluR2-lacking) at the synapse 12 h after repeated morphine treatment, affecting the magnitude of long-term depression at hippocampal neurons. We propose that morphine-induced changes in glutamatergic synaptic transmission in the hippocampus may play an important role in the neuroadaptations induced by repeated morphine administration.</description><subject>(2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino-2-hydroxypropyl](phenylmethyl)phosphinic acid hydrochloride</subject><subject>2-amino-5-phosphonovalerate</subject><subject>ACSF</subject><subject>AMPA</subject><subject>AMPAR</subject><subject>analysis of variance</subject><subject>Animals</subject><subject>ANOVA</subject><subject>artificial cerebral spinal fluid</subject><subject>CGP55845</subject><subject>d-APV</subject><subject>EPSC</subject><subject>excitatory postsynaptic currents</subject><subject>Excitatory Postsynaptic Potentials - drug effects</subject><subject>Excitatory Postsynaptic Potentials - physiology</subject><subject>extracellular field excitatory postsynaptic potential</subject><subject>fEPSP</subject><subject>fiber volley</subject><subject>GABA Antagonists - pharmacology</subject><subject>HFS</subject><subject>high-frequency stimulation</subject><subject>immunoprecipitation</subject><subject>Joro spider toxin</subject><subject>JST</subject><subject>LFS</subject><subject>long-term depression</subject><subject>long-term potentiation</subject><subject>Long-Term Potentiation - drug effects</subject><subject>Long-Term Potentiation - physiology</subject><subject>low-frequency stimulation</subject><subject>LTD</subject><subject>LTP</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Morphine - pharmacology</subject><subject>N-(2,6-dimethylphenylcarbamoylmethyl)triethylammonium</subject><subject>N-methyl-d-aspartate</subject><subject>N-methyl-d-aspartate receptor</subject><subject>NMDA</subject><subject>NMDAR</subject><subject>paired-pulse facilitation</subject><subject>philanthotoxin</subject><subject>Phosphinic Acids - pharmacology</subject><subject>Phosphorylation</subject><subject>Phtx</subject><subject>picrotoxin</subject><subject>Picrotoxin - pharmacology</subject><subject>postsynaptic density</subject><subject>PPF</subject><subject>Propanolamines - pharmacology</subject><subject>Protein Subunits - drug effects</subject><subject>Protein Subunits - genetics</subject><subject>PSD</subject><subject>PTX</subject><subject>QX314</subject><subject>Receptors, AMPA - biosynthesis</subject><subject>Receptors, AMPA - deficiency</subject><subject>Receptors, AMPA - drug effects</subject><subject>Receptors, AMPA - genetics</subject><subject>Receptors, AMPA - physiology</subject><subject>rectification index</subject><subject>Synapses - drug effects</subject><subject>Synapses - physiology</subject><subject>Synaptic Transmission - drug effects</subject><subject>Synaptic Transmission - physiology</subject><subject>ventral tegmental area</subject><subject>VTA</subject><subject>α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid</subject><subject>α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor</subject><issn>0026-895X</issn><issn>1521-0111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1u1DAUhS0EokNhyxJ5CQsPthPnZ4MUVdCONBVVAYmd5TjXHUNiW3amangrlrwEz4SrgREsWF1L99zvHOsg9JzRNWO8fD35cc1ou6YVLSh7gFZMcEYoY-whWlHKK9K04vMJepLSF0pZKRr6GJ1wykTblvUK_dg4HUElGPDGJYiz9Q57g8_H_awmNQO-Bg1h9hFzslX6q3U3-Od30k3WeVKQ3TJEf7cQQSaYd8tISmKTv1Pf_Aj4KvqQeVbjTtsBv-wur7pXR2DCasYXNgSv1RTUiD8sToUECe9DDnENAbL_gC99DDvrAHdDNrVpjuo-5VP0yKgxwbPf8xR9evf249kF2b4_35x1W6LLopkJU5qVfc95DaxVDVWqbnVT06ZXBTNcG2W46YuhEkIZXZpKQCl007dsANMbXZyiNwdu2PcTDBpcDjDKEO2k4iK9svLfjbM7eeNvJW9q3lYiA9YHgI4-pQjmeMuovC9R5hLzu5WHEvPBi78dj_I_rWVBcxBA_vethSiTtuA0DDaCnuXg7f_YvwD5arHr</recordid><startdate>201005</startdate><enddate>201005</enddate><creator>Billa, Sophie K.</creator><creator>Liu, Jie</creator><creator>Bjorklund, Nicole L.</creator><creator>Sinha, Namita</creator><creator>Fu, Yu</creator><creator>Shinnick-Gallagher, Patricia</creator><creator>Morón, Jose A.</creator><general>Elsevier Inc</general><general>The American Society for Pharmacology and Experimental Therapeutics</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>201005</creationdate><title>Increased Insertion of Glutamate Receptor 2-Lacking α-Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid (AMPA) Receptors at Hippocampal Synapses upon Repeated Morphine Administration</title><author>Billa, Sophie K. ; Liu, Jie ; Bjorklund, Nicole L. ; Sinha, Namita ; Fu, Yu ; Shinnick-Gallagher, Patricia ; Morón, Jose A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-1ac14bb227e19a80aa79c8708ba31f2cfaf2fb3d655afc4f65e45c8b91defbfc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>(2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino-2-hydroxypropyl](phenylmethyl)phosphinic acid hydrochloride</topic><topic>2-amino-5-phosphonovalerate</topic><topic>ACSF</topic><topic>AMPA</topic><topic>AMPAR</topic><topic>analysis of variance</topic><topic>Animals</topic><topic>ANOVA</topic><topic>artificial cerebral spinal fluid</topic><topic>CGP55845</topic><topic>d-APV</topic><topic>EPSC</topic><topic>excitatory postsynaptic currents</topic><topic>Excitatory Postsynaptic Potentials - drug effects</topic><topic>Excitatory Postsynaptic Potentials - physiology</topic><topic>extracellular field excitatory postsynaptic potential</topic><topic>fEPSP</topic><topic>fiber volley</topic><topic>GABA Antagonists - pharmacology</topic><topic>HFS</topic><topic>high-frequency stimulation</topic><topic>immunoprecipitation</topic><topic>Joro spider toxin</topic><topic>JST</topic><topic>LFS</topic><topic>long-term depression</topic><topic>long-term potentiation</topic><topic>Long-Term Potentiation - drug effects</topic><topic>Long-Term Potentiation - physiology</topic><topic>low-frequency stimulation</topic><topic>LTD</topic><topic>LTP</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Morphine - pharmacology</topic><topic>N-(2,6-dimethylphenylcarbamoylmethyl)triethylammonium</topic><topic>N-methyl-d-aspartate</topic><topic>N-methyl-d-aspartate receptor</topic><topic>NMDA</topic><topic>NMDAR</topic><topic>paired-pulse facilitation</topic><topic>philanthotoxin</topic><topic>Phosphinic Acids - pharmacology</topic><topic>Phosphorylation</topic><topic>Phtx</topic><topic>picrotoxin</topic><topic>Picrotoxin - pharmacology</topic><topic>postsynaptic density</topic><topic>PPF</topic><topic>Propanolamines - pharmacology</topic><topic>Protein Subunits - drug effects</topic><topic>Protein Subunits - genetics</topic><topic>PSD</topic><topic>PTX</topic><topic>QX314</topic><topic>Receptors, AMPA - biosynthesis</topic><topic>Receptors, AMPA - deficiency</topic><topic>Receptors, AMPA - drug effects</topic><topic>Receptors, AMPA - genetics</topic><topic>Receptors, AMPA - physiology</topic><topic>rectification index</topic><topic>Synapses - drug effects</topic><topic>Synapses - physiology</topic><topic>Synaptic Transmission - drug effects</topic><topic>Synaptic Transmission - physiology</topic><topic>ventral tegmental area</topic><topic>VTA</topic><topic>α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid</topic><topic>α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Billa, Sophie K.</creatorcontrib><creatorcontrib>Liu, Jie</creatorcontrib><creatorcontrib>Bjorklund, Nicole L.</creatorcontrib><creatorcontrib>Sinha, Namita</creatorcontrib><creatorcontrib>Fu, Yu</creatorcontrib><creatorcontrib>Shinnick-Gallagher, Patricia</creatorcontrib><creatorcontrib>Morón, Jose A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Billa, Sophie K.</au><au>Liu, Jie</au><au>Bjorklund, Nicole L.</au><au>Sinha, Namita</au><au>Fu, Yu</au><au>Shinnick-Gallagher, Patricia</au><au>Morón, Jose A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased Insertion of Glutamate Receptor 2-Lacking α-Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid (AMPA) Receptors at Hippocampal Synapses upon Repeated Morphine Administration</atitle><jtitle>Molecular pharmacology</jtitle><addtitle>Mol Pharmacol</addtitle><date>2010-05</date><risdate>2010</risdate><volume>77</volume><issue>5</issue><spage>874</spage><epage>883</epage><pages>874-883</pages><issn>0026-895X</issn><eissn>1521-0111</eissn><abstract>Evidence suggests that the long-term adaptations in the hippocampus after repeated drug treatment may parallel its role during memory formation. The neuroplasticity that subserves learning and memory is also believed to underlie addictive processes. We have reported previously that repeated morphine administration alters local distribution of endocytic proteins at hippocampal synapses, which could in turn affect expression of glutamate receptors. Glutamatergic systems, including α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs), are believed to be involved in opiate-induced neuronal and behavioral plasticity, although the mechanisms underlying these effects are only beginning to be understood. The present study further examines the effects of repeated morphine administration on the expression and composition of AMPARs and the functional ramifications. Twelve hours after the last morphine injection, we observed an increased expression of AMPARs lacking glutamate receptor (GluR) 2 in hippocampal synaptic fractions. Immunoblotting studies show that 12 h after morphine treatment, GluR1 subunits are increased at the postsynaptic density (PSD) and at extrasynaptic sites, whereas GluR3 subunits are only increased at the PSD, and they show how this alters receptor subunit composition. In addition, we provide electrophysiological evidence that AMPARs are switched to Ca2+-permeable (GluR2-lacking) at the synapse 12 h after repeated morphine treatment, affecting the magnitude of long-term depression at hippocampal neurons. We propose that morphine-induced changes in glutamatergic synaptic transmission in the hippocampus may play an important role in the neuroadaptations induced by repeated morphine administration.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>20159947</pmid><doi>10.1124/mol.109.060301</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0026-895X |
ispartof | Molecular pharmacology, 2010-05, Vol.77 (5), p.874-883 |
issn | 0026-895X 1521-0111 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2872965 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry |
subjects | (2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino-2-hydroxypropyl](phenylmethyl)phosphinic acid hydrochloride 2-amino-5-phosphonovalerate ACSF AMPA AMPAR analysis of variance Animals ANOVA artificial cerebral spinal fluid CGP55845 d-APV EPSC excitatory postsynaptic currents Excitatory Postsynaptic Potentials - drug effects Excitatory Postsynaptic Potentials - physiology extracellular field excitatory postsynaptic potential fEPSP fiber volley GABA Antagonists - pharmacology HFS high-frequency stimulation immunoprecipitation Joro spider toxin JST LFS long-term depression long-term potentiation Long-Term Potentiation - drug effects Long-Term Potentiation - physiology low-frequency stimulation LTD LTP Male Mice Mice, Inbred C57BL Mice, Knockout Morphine - pharmacology N-(2,6-dimethylphenylcarbamoylmethyl)triethylammonium N-methyl-d-aspartate N-methyl-d-aspartate receptor NMDA NMDAR paired-pulse facilitation philanthotoxin Phosphinic Acids - pharmacology Phosphorylation Phtx picrotoxin Picrotoxin - pharmacology postsynaptic density PPF Propanolamines - pharmacology Protein Subunits - drug effects Protein Subunits - genetics PSD PTX QX314 Receptors, AMPA - biosynthesis Receptors, AMPA - deficiency Receptors, AMPA - drug effects Receptors, AMPA - genetics Receptors, AMPA - physiology rectification index Synapses - drug effects Synapses - physiology Synaptic Transmission - drug effects Synaptic Transmission - physiology ventral tegmental area VTA α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor |
title | Increased Insertion of Glutamate Receptor 2-Lacking α-Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid (AMPA) Receptors at Hippocampal Synapses upon Repeated Morphine Administration |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T08%3A16%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20Insertion%20of%20Glutamate%20Receptor%202-Lacking%20%CE%B1-Amino-3-hydroxy-5-methyl-4-isoxazole%20Propionic%20Acid%20(AMPA)%20Receptors%20at%20Hippocampal%20Synapses%20upon%20Repeated%20Morphine%20Administration&rft.jtitle=Molecular%20pharmacology&rft.au=Billa,%20Sophie%20K.&rft.date=2010-05&rft.volume=77&rft.issue=5&rft.spage=874&rft.epage=883&rft.pages=874-883&rft.issn=0026-895X&rft.eissn=1521-0111&rft_id=info:doi/10.1124/mol.109.060301&rft_dat=%3Cpubmed_cross%3E20159947%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/20159947&rft_els_id=S0026895X24026804&rfr_iscdi=true |